583 results
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options
21 Nov 2021 – From PCR London Valves 2021
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options - Part 1 - Best long-term outcomes start with the first procedure
21 Nov 2021 – From PCR London Valves
In this session from PCR London Valve 2021 dedicated to TAVI, mitral, and tricuspid, let's examine the issues related to the lifetime patient journey faced by many patients, starting with an analysis of severe aortic stenosis: how to identify the most important factors when considering the...
New 2021 ESC heart failure and valvular heart diseases guidelines : impact on secondary mitral regurgitation management
21 Nov 2021 – From PCR London Valves 2021
Join Ralph Stephan Von Bardeleben and Marco Metra if you want to learn about the new ESC 2021 guidelines in heart failure management and the key interconnections between the heart failure and the valvular heart diseases guidelines, as well as to understand how this will improve...
Mitral valve disease: state-of-the-art
21 Nov 2021 – From PCR London Valves 2021
Did you ever wonder what an expert surgeon can achieve today in mitral repair? Have you ever wondered when to treat an asymptomatic patient with severe mitral regurgitation? These are some of the questions this session from PCR London Valves 2021 will try to answer.
Transcatheter mitral interventions: the future
21 Nov 2021 – From PCR London Valves 2021
What could be the future of transcatheter mitral valve intervention? Will it be repair or replacement? What are the current limitations? Find parts of the answers to these questions, and many others, in this session shot during the PCR LV 2021 Congress.
Mitral valve disease: guidelines and beyond
21 Nov 2021 – From PCR London Valves 2021
In this session from PCR London Valves 2021 dedicated to the new guidelines relating to the management of mitral valve disease, discover how to apply them in your everyday clinical practice to the care of your patients through presentations, interviews, heart team discussions, a live case...
Best of #AHA21 Scientific Sessions: coronary and valvular heart disease trials
14 Nov 2021
Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.
Author
Role of fusion imaging for mitral valve repair
08 Oct 2021 – From AICT-AsiaPCR 2021
If you wish to know more about the concept of real-time fusion imaging of echocardiography and fluoroscopy, this session is for you: find out more about the use of fusion imaging and learn how to use this process in the management of procedures involving mitral valves.
Abstracts on mitral valve repair
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover two abstracts on mitral valve repair, and learn more about the outcomes of aortic and tricuspid regurgitation after percutaneous mitral commissurotomy.
Tailoring mitral repair and optimising clinical outcomes using MitraClip G4
27 Sep 2021 – From PCR Tokyo Valves 2021
Using the one-year results of the EXPAND study and the 30-day results of the EXPAND G4 study, this session highlights the value of the latest generation of MitraClip technologies, providing an overview of the strengths of the MitraClip G4 and its practical use on 2 case...
